Connecting you to content on EBSCOhost

Works by Norris, Lauren D.

Results: 4

1

Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.

Published in:

Genome Biology & Evolution, 2017, v. 9, n. 6, p. 1673, doi. 10.1093/gbe/evx126

By:

Parobek, Christian M.;
Parr, Jonathan B.;
Brazeau, Nicholas F.;
Lon, Chanthap;
Chaorattanakawee, Suwanna;
Gosi, Panita;
Barnett, Eric J.;
Norris, Lauren D.;
Meshnick, Steven R.;
Spring, Michele D.;
Lanteri, Charlotte A.;
Bailey, Jeffrey A.;
Saunders, David L.;
Lin, Jessica T.;
Juliano, Jonathan J.

Publication type:

Article

2

A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis.

Published in:

Science Translational Medicine, 2023, v. 15, n. 708, p. 1, doi. 10.1126/scitranslmed.abn7491

By:

Peters, Diane E.;
Norris, Lauren D.;
Tenora, Lukáš;
Šnajdr, Ivan;
Ponti, András K.;
Zhu, Xiaolei;
Sakamoto, Shinji;
Veeravalli, Vijayabhaskar;
Pradhan, Manisha;
Alt, Jesse;
Thomas, Ajit G.;
Majer, Pavel;
Rais, Rana;
McDonald, Christine;
Slusher, Barbara S.

Publication type:

Article

3

Variation in bony landmarks and predictors of success with sacral neuromodulation.

Published in:

International Urogynecology Journal, 2019, v. 30, n. 11, p. 1973, doi. 10.1007/s00192-019-03883-3

By:

Husk, Katherine E.;
Norris, Lauren D.;
Willis-Gray, Marcella G.;
Borawski, Kristy M.;
Geller, Elizabeth J.

Publication type:

Article

4

A Novel Oral Glutamate Carboxypeptidase II Inhibitor for the Treatment of Inflammatory Bowel Disease.

Published in:

FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R3089

By:

Pradhan, Manisha;
Peters, Diane E.;
Norris, Lauren D.;
Thomas, Ajit G.;
Rais, Rana;
Slusher, Barbara S.

Publication type:

Article